A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells
Year: 2004
Type: article
Institution: Taiho Pharmaceutical (Japan)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Taiho Pharmaceutical
OpenAlex ID: W1974054076
